Cardiovascular Surgery Research Lab, Center for Preclinical Surgical and Interventional Research, The Texas Heart Institute, 6770 Bertner Avenue, Houston, TX 77030, USA
David Dworaczyk
Cardiovascular Surgery Research Lab, Center for Preclinical Surgical and Interventional Research, The Texas Heart Institute, 6770 Bertner Avenue, Houston, TX 77030, USA
Julia Whitehorn
Cardiovascular Surgery Research Lab, Center for Preclinical Surgical and Interventional Research, The Texas Heart Institute, 6770 Bertner Avenue, Houston, TX 77030, USA
Ke Li
Cardiovascular Surgery Research Lab, Center for Preclinical Surgical and Interventional Research, The Texas Heart Institute, 6770 Bertner Avenue, Houston, TX 77030, USA
Cristiano de Oliveira Cardoso
Cardiovascular Surgery Research Lab, Center for Preclinical Surgical and Interventional Research, The Texas Heart Institute, 6770 Bertner Avenue, Houston, TX 77030, USA
Abdelmotagaly Elgalad
Cardiovascular Surgery Research Lab, Center for Preclinical Surgical and Interventional Research, The Texas Heart Institute, 6770 Bertner Avenue, Houston, TX 77030, USA
During the preclinical research process, multiple factors can be difficult to implement without the careful consideration and planning of each step. As research has become more advanced with the use of increasingly complex technology, animal models have also become essential for understanding the potential impact of devices, drug therapies, and surgical techniques on humans before clinical trials are conducted. The use of an in vivo animal model is a key and necessary step in the progression of preclinical research studies that will lead to future medical inventions and innovation. Here, we describe the three phases of effectively designing a preclinical research protocol: the research, preprocedural planning, and experimental phases. Furthermore, we provide researchers with guidance through these phases and discuss important considerations.